Neuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call

Rhea-AI Summary

MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, a medical technology company, will release its third quarter financial results on November 9, 2021, before market open. A conference call to discuss these results is scheduled for 8:30 a.m. ET that day, available via webcast on ir.neuronetics.com. Participants can dial in using (877) 472-8990 for U.S. callers or +1 (629) 228-0778 for international callers, referencing code 3891687. The call will be recorded and available for replay for 60 days. Neuronetics focuses on products that enhance the quality of life for neurohealth patients.

MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it plans to release third quarter financial and operating results prior to market open on Tuesday, November 9, 2021. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

The conference call will be broadcast live in listen-only mode via a webcast on the Company’s investor relations website at ir.neuronetics.com. To listen to the conference call on your telephone, please dial (877) 472-8990 for United States callers or +1 (629) 228-0778 for international callers and reference confirmation code 3891687, approximately ten minutes prior to start time. The replay will be available on the Company's website for approximately 60 days.

About Neuronetics

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Additional information can be found at www.neuronetics.com. 

Investor Contact:

Mike Vallie or Mark Klausner
Westwicke Partners
443-213-0499
ir@neuronetics.com 

Media Contact:

EvolveMKD
646.517.4220
NeuroStar@evolvemkd.com 

FAQ

When will Neuronetics release its third quarter financial results for 2021?

Neuronetics will release its third quarter financial results on November 9, 2021, before market open.

What time is the Neuronetics conference call scheduled for November 9, 2021?

The Neuronetics conference call is scheduled for 8:30 a.m. Eastern Time on November 9, 2021.

How can I listen to the Neuronetics third quarter results conference call?

You can listen to the conference call live via webcast at ir.neuronetics.com or by dialing (877) 472-8990 for U.S. callers and +1 (629) 228-0778 for international callers.

What is the conference call confirmation code for the Neuronetics call?

The confirmation code for the Neuronetics conference call is 3891687.

Will there be a replay of the Neuronetics conference call?

Yes, a replay of the Neuronetics conference call will be available on their website for approximately 60 days.